The following tables present the loss per share calculations for the three-month periods ended September 30, 2012 and 2011. The Company excluded all options and warrants for the calculations of diluted loss per share for the quarters ended September 30, 2012 and 2011 because such common stock equivalents would be antidilutive to the loss per share.

	Three Months Ended
Basic Loss Per Common Share	September 30, 2012			September 30, 2011
(in thousands, except per share amounts)

Net loss to common shareholders	$	(10,294	)	$	(743	)
Weighted average common shares outstanding		17,961			17,953
Basic loss per common share	$	(0.57	)	$	(0.04	)

	Three Months Ended
Diluted Loss Per Common Share	September 30, 2012			September 30, 2011
(in thousands, except per share amounts)

Net loss to common shareholders	$	(10,294	)	$	(743	)
Weighted average shares outstanding		17,961			17,953
Dilutive effects of assumed conversion and exercise of common stock options, warrants and restricted stock		0			0
Weighted average common and dilutive potential common shares outstanding		17,961			17,953
Diluted loss per common share	$	(0.57	)	$	(0.04	)

The following tables present the loss per share calculations for the nine-month periods ended September 30, 2012 and 2011. The Company excluded all options and warrants for the calculations of diluted loss per share for the nine-months ended September 30, 2012 and 2011 because such common stock equivalents would be antidilutive to the loss per share.

	Nine Months Ended
Basic Loss Per Common Share	September 30, 2012			September 30, 2011
(in thousands, except per share amounts)

Net loss to common shareholders	$	(23,186	)	$	(457	)
Weighted average common shares outstanding		17,958			17,886
Basic loss per common share	$	(1.29	)	$	(0.03	)

	Nine Months Ended
Diluted Loss Per Common Share	September 30, 2012			September 30, 2011
(in thousands, except per share amounts)

Net loss to common shareholders	$	(23,186	)	$	(457	)
Weighted average shares outstanding		17,958			17,886
Dilutive effects of assumed conversion and exercise of common stock options, warrants and restricted stock		0			0
Weighted average common and dilutive potential common shares outstanding		17,958			17,886
Diluted loss per common share	$	(1.29	)	$	(0.03	)